MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Neogen Corporation Long Term Debt Current 2011-2026 | NEOG
Annual Long Term Debt Current Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.64 M | 5.1 M | 3.28 M | 1.44 M | 1.28 M | 1.05 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.64 M | 1.05 M | 2.97 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M |  USA |
 |
Bioventus
BVS
|
3.3 M | $ 9.0 | 1.47 % | $ 600 M | USA |
 |
Brainsway Ltd.
BWAY
|
824 K | $ 13.99 | 2.49 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 26.24 | 1.59 % | $ 729 M | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 154.17 | 1.45 % | $ 7.64 B | USA |
 |
DexCom
DXCM
|
21.6 M | $ 68.54 | 3.32 % | $ 26.7 B | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 17.77 | 2.6 % | $ 947 M | USA |
 |
Guardant Health
GH
|
27.7 M | $ 88.16 | 1.12 % | $ 11.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | $ 103.95 | 0.1 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 15.57 | 4.15 % | $ 471 M | USA |
|
Biodesix
BDSX
|
719 K | $ 17.22 | -0.4 % | $ 2.23 B | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 101.08 | 3.55 % | $ 8.34 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
41 K | $ 2.88 | 1.23 % | $ 93.5 K | USA |
 |
IQVIA Holdings
IQV
|
93 M | $ 169.85 | 3.01 % | $ 29.2 B | USA |
 |
Danaher Corporation
DHR
|
199 M | $ 195.65 | 2.23 % | $ 139 B | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
79 M | $ 121.72 | 2.04 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 198.39 | -0.28 % | $ 22 B | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B |  Niderland |
 |
BioNano Genomics
BNGO
|
2.99 M | $ 1.12 | 0.91 % | $ 1.42 M | USA |
 |
DarioHealth Corp.
DRIO
|
111 K | $ 9.28 | 10.24 % | $ 263 M | Israel |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.39 | 1.76 % | $ 1.07 B | USA |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 78.83 | 0.41 % | $ 5.32 B | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
448 K | $ 1.41 | 3.68 % | $ 423 M | USA |
 |
Co-Diagnostics
CODX
|
838 K | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 458.61 | 1.1 % | $ 13.2 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
35.1 M | $ 1 220.43 | 1.77 % | $ 25.2 B |  Schweiz |
 |
Celcuity
CELC
|
172 K | $ 115.07 | 0.15 % | $ 4.54 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
451 K | $ 18.31 | 5.23 % | $ 410 M | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
7.64 M | $ 201.15 | 1.76 % | $ 19.8 B | USA |
 |
OPKO Health
OPK
|
12.6 M | $ 1.2 | 0.84 % | $ 833 M | USA |